Cytoskeleton-Membrane Uncoupling in Duchenne Muscular Dystrophy: Implications for Newborn Screening and Early...

Area of Science:

• Muscle physiology and disease
• Cellular biomechanics
• Biomolecular engineering

Background:

• The muscle cytoskeleton (sarcomeres, costameres, intermediate filaments) ensures mechanical stability and force transmission.
• Duchenne muscular dystrophy (DMD) involves dystrophin loss, disrupting cytoskeleton-sarcolemma coupling and leading to myofiber injury.
• Current DMD diagnosis often occurs after irreversible tissue damage, missing early pathogenic events.

Purpose of the Study:

• To reframe Duchenne muscular dystrophy (DMD) as a disorder initiated by early mechanical instability.
• To highlight the potential for therapeutic intervention during the pre-symptomatic phase.
• To emphasize cytoskeleton-membrane uncoupling as a key early and actionable event in DMD.

Main Methods:

• Review of existing literature on muscle cytoskeleton function and DMD pathogenesis.
• Analysis of the temporal relationship between genetic defect, cellular changes, and clinical diagnosis in DMD.
• Conceptual framework development for early intervention strategies.

Main Results:

• DMD is characterized by early disruption of mechanical continuity between the muscle cytoskeleton and sarcolemma.
• Newborn screening allows for detection of DMD before significant muscle pathology develops.
• Cytoskeleton-membrane uncoupling precedes substantial tissue remodeling and clinical symptoms.

Conclusions:

• Cytoskeleton-membrane uncoupling is an early, potentially targetable event in Duchenne muscular dystrophy.
• Early intervention focused on preserving cytoskeletal integrity may limit disease progression.
• A revised understanding of DMD pathogenesis supports a shift towards pre-symptomatic therapeutic strategies.